News

FDA approves Plan B One-Step OTC for all ages


 

The Food and Drug Administration approved the emergency contraceptive Plan B One-Step for over-the-counter sale for women and girls of all ages, ending years of litigation over the drug’s status.

On June 20, the FDA complied with an order from the U.S. District Court in New York and approved the one-pill levonorgestrel product with no point-of-sale restrictions. The drug was originally approved without a prescription for women aged 17 and older in 2009. Earlier this year, the agency granted nonprescription sale for women aged 15 and older. This latest approval will make the drug available to all women of childbearing age.

While reproductive rights advocates praised the Obama administration’s decision not to continue fighting greater access to emergency contraception in the courts, they urged the FDA to approve lower-cost generic options for over-the-counter sale.

mschneider@frontlinemedcom.com

On Twitter @MaryEllenNY

Recommended Reading

Most ovarian cysts in adolescents resolve
MDedge ObGyn
Feds push to restrict Plan B sales to young teens
MDedge ObGyn
LARC use leads to dramatic drop in teen pregnancies
MDedge ObGyn
Prenatal classes influence New Zealand moms' decision to vaccinate
MDedge ObGyn
Tdap vaccine during pregnancy bests 'postpartum cocooning' approach
MDedge ObGyn
Teen birth rate down almost 50% since 1991
MDedge ObGyn
More than half of eligible girls don't get first HPV vaccine
MDedge ObGyn
Feds back down on emergency contraception
MDedge ObGyn
Estrogen replacement eases weight-gain anxiety in girls with anorexia
MDedge ObGyn
CDC study finds 56% drop in HPV infections
MDedge ObGyn

Related Articles